Osteoarthritis year in review 2015: clinical.
Study Goal
The researchers aimed to review clinical studies on osteoarthritis treatments, including Chondroitin sulfate, to assess its symptom and structural outcomes.
Results Summary
The study reported symptom outcomes for Chondroitin sulfate among pharmacologic treatments for osteoarthritis, indicating its inclusion in clinical research, but specific efficacy details were not highlighted. Structural outcomes were also noted for Chondroitin sulfate, suggesting potential benefits in osteoarthritis management.
Population
Adults aged 19+ with osteoarthritis.
Effective Dosage
Not available
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
methotrexate | neutral | symptom outcomes | humans | - | reported for | #1 |
adalimumab | neutral | symptom outcomes | humans | - | reported for | #2 |
anti-nerve growth factor monoclonal antibodies | neutral | symptom outcomes | humans | - | reported for | #3 |
strontium ranelate | neutral | symptom outcomes | humans | - | reported for | #4 |
bisphosphonates | neutral | symptom outcomes | humans | - | reported for | #5 |
glucosamine | neutral | symptom outcomes | humans | - | reported for | #6 |
chondroitin sulfate | neutral | symptom outcomes | humans | - | reported for | #7 |
strontium ranelate | neutral | structural outcomes | humans | - | reported for | #8 |
recombinant human fibroblast growth factor 18 | neutral | structural outcomes | humans | - | reported for | #9 |
glucosamine and chondroitin sulfate | neutral | structural outcomes | humans | - | reported for | #10 |
neuromuscular exercise | neutral | symptom outcomes | humans | - | reported for | #11 |
quadriceps strengthening | neutral | symptom outcomes | humans | - | reported for | #12 |
weight reduction and maintenance | neutral | symptom outcomes | humans | - | reported for | #13 |
TENS | neutral | symptom outcomes | humans | - | reported for | #14 |
therapeutic ultrasound | neutral | symptom outcomes | humans | - | reported for | #15 |
stepped care strategies | neutral | symptom outcomes | humans | - | reported for | #16 |
cognitive behavior therapy for sleep disturbance | neutral | symptom outcomes | humans | - | reported for | #17 |
acupuncture | neutral | symptom outcomes | humans | - | reported for | #18 |
gait modification | neutral | symptom outcomes | humans | - | reported for | #19 |
booster physical therapy | neutral | symptom outcomes | humans | - | reported for | #20 |
a web-based therapeutic exercise resource center for knee OA | neutral | symptom outcomes | humans | - | reported for | #21 |
hip physical therapy for hip OA | neutral | symptom outcomes | humans | - | reported for | #22 |
joint protection and hand exercises for hand OA | neutral | symptom outcomes | humans | - | reported for | #23 |
patellofemoral bracing | neutral | structure outcomes | humans | - | reported for | #24 |
The purpose of this review is to highlight clinical research in osteoarthritis (OA). A literature search was conducted using PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) with the search terms "osteoarthritis [All Fields] AND treatment [All Fields]" and the following limits activated: humans, English language, all adult 19+ years, published between April 1, 2014 and April 1, 2015. A second literature search was then conducted with the search terms "osteoarthritis [All Fields] AND epidemiology [All Fields]", with the same limits. Reports of surgical outcome, case series, surgical technique, tissue sample or culture studies, trial protocols, and pilot studies were excluded. Of 1523, 150 were considered relevant. Among epidemiologic and observational clinical studies, themes included physical activity, early knee OA, and confidence/instability/falls. Symptom outcomes of pharmacologic treatments were reported for methotrexate, adalimumab, anti-nerve growth factor monoclonal antibodies, strontium ranelate, bisphosphonates, glucosamine, and chondroitin sulfate, and structural outcomes of pharmacologic treatments for strontium ranelate, recombinant human fibroblast growth factor 18, and glucosamine and chondroitin sulfate. Symptom outcomes of non-pharmacologic interventions were reported for: neuromuscular exercise, quadriceps strengthening, weight reduction and maintenance, TENS, therapeutic ultrasound, stepped care strategies, cognitive behavior therapy for sleep disturbance, acupuncture, gait modification, booster physical therapy, a web-based therapeutic exercise resource center for knee OA; hip physical therapy for hip OA; and joint protection and hand exercises for hand OA. Structure outcomes of non-pharmacologic interventions were reported for patellofemoral bracing.